In support of a role for stromal AR in cancer aggressiveness, it has been shown that AR targeting in CAFs reduces skin cancer aggressiveness traits (26) or even inhibit the development of chemo-resistant skin cancers (27). The gene discussed is AR; the disease is skin cancer.